Hopp til innhold

Get alerts of updates about «Transperineal biopsy compared with transrectal biopsy in suspected prostate cancer - Protocol for Health Technology Assessment»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel your alerts and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Transperineal biopsy compared with transrectal biopsy in suspected prostate cancer - Protocol for Health Technology Assessment

Project

Transperineal biopsy compared with transrectal biopsy in suspected prostate cancer - Protocol for Health Technology Assessment - project description

Published Updated

The Norwegian Institute of Public Health has been commissioned to perform a health technology assessment of transperineal biopsy compared with transrectal biopsy on suspicion of prostate cancer.


Summary

Transrectal prostate biopsy has traditionally been used in suspected prostate cancer. In the transrectal approach, the biopsy needle is inserted through the rectal wall to collect tissue samples of the prostate. The method carries a risk of infection, and antibiotics are therefore given prophylactically. Due to the risk of infections and the fact that in recent years there has been an increased incidence of sepsis and antibiotic resistance, a transperineal approach has been used to a greater extent. In the transperineal approach, the biopsy needle is inserted through the perineum instead of through the rectal wall, and it is assumed that the procedure entails lower risk of infections.

 

The Norwegian Institute of Public Health has been commissioned to perform a health technology assessment of transperineal biopsy compared with transrectal biopsy on suspicion of prostate cancer. The health technology assessment will include a systematic review of the transperineally approach compared with the transrectally approach as well as an evaluation of diagnostic accuracy depending on the method used. For diagnostic accuracy, we will include systematic reviews published in the last five years and describe them in a table with quality assessment and results. The health technology assessment will also include a health economic evaluation.

 

See the full project description at Cristin for more information about results, researchers, contact information etc.

Project participants

Project leader

Liv Giske, Norwegian Institute of Public Health

Project participants

Tonje Lehne Refsdal, Norwegian Institute of Public Health
Signe Louise Forsetlund, Norwegian Institute of Public Health
Hilde Risstad, Norwegian Institute of Public Health
Anna Karina Stoinska-Schneider, Norwegian Institute of Public Health

Start

25.03.2021

End

25.03.2022

Status

Active

Project owner/ Project manager

Norwegian Institute of Public Health

Project description

Prosjektplan Transperineal.pdf

Project manager

Liv Giske